We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
+$341M
Cap. Flow %
1.23%
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$113M
2
AAPL icon
Apple
AAPL
+$69M
3
PFE icon
Pfizer
PFE
+$57M
4
VZ icon
Verizon
VZ
+$50.4M
5
MSFT icon
Microsoft
MSFT
+$48.6M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$100M
2
LIN icon
Linde
LIN
+$85.1M
3
ABMD
Abiomed Inc
ABMD
+$55.4M
4
RACE icon
Ferrari
RACE
+$51.7M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 27.12%
2 Healthcare 20.97%
3 Financials 10.86%
4 Consumer Discretionary 10.19%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMC icon
451
FMC
FMC
$1.36B
$8.9M 0.03%
71,281
+720
+1% +$88.3K
SHLS icon
452
Shoals Technologies Group
SHLS
$1.16B
$8.88M 0.03%
+359,895
New +$8.69M
OKE icon
453
Oneok
OKE
$59.1B
$8.82M 0.03%
134,187
+105,910
+375% +$6.51M
ATO icon
454
Atmos Energy
ATO
$27.6B
$8.76M 0.03%
78,146
-50,785
-39% -$5.59M
MDRX
455
DELISTED
Veradigm Inc. Common Stock
MDRX
$8.66M 0.03%
490,650
+162,800
+50% +$2.73M
MEDP icon
456
Medpace
MEDP
$17.3B
$8.6M 0.03%
40,500
-4,100
-9% -$819K
ALKS icon
457
Alkermes
ALKS
$7.73B
$8.58M 0.03%
328,499
-1,734
-0.5% -$41.5K
NBIX icon
458
Neurocrine Biosciences
NBIX
$15.3B
$8.46M 0.03%
70,819
-20,504
-22% -$2.4M
EXEL icon
459
Exelixis
EXEL
$14.2B
$8.43M 0.03%
525,653
+211,749
+67% +$3.45M
DEI icon
460
Douglas Emmett
DEI
$1.75B
$8.37M 0.03%
534,057
+6,380
+1% +$106K
PHR icon
461
Phreesia
PHR
$637M
$8.36M 0.03%
258,273
+2,245
+0.9% +$60.9K
MTCH icon
462
Match Group
MTCH
$10.1B
$8.35M 0.03%
201,372
-9,075
-4% -$410K
FDS icon
463
Factset
FDS
$9.77B
$8.32M 0.03%
20,726
-23,552
-53% -$10M
LICY
464
DELISTED
Li-Cycle Holdings Corp.
LICY
$8.29M 0.03%
217,733
+17,926
+9% +$805K
CNC icon
465
Centene
CNC
$33.1B
$8.13M 0.03%
99,168
-13,899
-12% -$1.14M
TTEK icon
466
Tetra Tech
TTEK
$9.42B
$8.11M 0.03%
279,460
– –
FANG icon
467
Diamondback Energy
FANG
$54.7B
$8.1M 0.03%
59,209
-147,459
-71% -$21.5M
KRTX
468
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$8.09M 0.03%
41,165
-222
-0.5% -$47.6K
DNLI icon
469
Denali Therapeutics
DNLI
$3.24B
$8.06M 0.03%
289,920
+41,148
+17% +$1.22M
VMRK
470
Vivmark Residential
VMRK
$49.7B
$8.06M 0.03%
136,610
-3,623
-3% -$227K
EME icon
471
Emcor
EME
$32.9B
$8.06M 0.03%
54,400
-11,000
-17% -$1.56M
VSH icon
472
Vishay Intertechnology
VSH
$4.91B
$8.05M 0.03%
373,025
+110,700
+42% +$2.34M
PNW icon
473
Pinnacle West Capital
PNW
$11.6B
$7.99M 0.03%
105,100
+26,900
+34% +$1.92M
DOO
474
Bombardier Recreational Products
DOO
$4.25B
$7.93M 0.03%
103,911
+90,683
+686% +$6.32M
AEIS icon
475
Advanced Energy
AEIS
$10.2B
$7.9M 0.03%
92,129
-3,043
-3% -$255K
17 18
19
20 21

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q4 2022 Portfolio in Review

As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
  • Axa added most to Tesla in Q4 2022, an estimated $113M increase.
  • Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
  • Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
  • Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
  • Axa opened 118 new positions and closed 119 in Q4 2022.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.